Pharmacopsychiatry

SJR Rank #6,116H-index: 88SJR: 0.868Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Georg Thieme Verlag

Country

Germany

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Medicine (miscellaneous)Q2
  • Pharmacology (medical)Q2
  • Psychiatry and Mental HealthQ2

Areas: Medicine

Most published research topics

Schizophrenia research and treatmentTreatment of Major DepressionBipolar Disorder and TreatmentElectroconvulsive Therapy StudiesNeurotransmitter Receptor Influence on BehaviorTryptophan and brain disordersStress Responses and CortisolAttention Deficit Hyperactivity DisorderNeuroscience and Neuropharmacology ResearchEpilepsy research and treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0306090120

Documents per Year

2022202508162432

Detailed Information

ISSN

1439-0795, 0176-3679

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.36

References per Document

40.81

Coverage

1984-2026

Scope

Covering advances in the fi eld of psychotropic drugs, Pharmaco psychiatry provides psychiatrists, neuroscientists and clinicians with key clinical insights and describes new avenues of research and treatment. The pharmacological and neurobiological bases of psychiatric disorders are discussed by presenting clinical and experimental research.

Metrics from SCImago Journal Rank 2025. View on SCImago